Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001759138-26-000026
Filing Date
2026-05-14
Accepted
2026-05-14 07:08:46
Documents
57
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q caba-20260331.htm   iXBRL 10-Q 2322356
2 EX-31.1 caba-ex31_1.htm EX-31.1 18644
3 EX-31.2 caba-ex31_2.htm EX-31.2 18621
4 EX-32.1 caba-ex32_1.htm EX-32.1 10974
5 EX-32.2 caba-ex32_2.htm EX-32.2 11578
  Complete submission text file 0001759138-26-000026.txt   7665742

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT caba-20260331.xsd EX-101.SCH 978779
61 EXTRACTED XBRL INSTANCE DOCUMENT caba-20260331_htm.xml XML 1095928
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39103 | Film No.: 26975804
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)